BLRX

BioLineRX
BLRX

Overview Fund Activity

26 hedge funds and large institutions have $1.97M invested in BioLineRX in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+6
Holders Change %
+30%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
5
Closed
3
Calls
$222K
Puts
$174K
Net Calls
+$48K
Net Calls Change
+$48K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$339K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$134K
3
RhumbLine Advisers
3
RhumbLine Advisers
Massachusetts
$21.7K
4
HF
4
HRT Financial
New York
$21K
5
GVAG
5
Great Valley Advisor Group
Delaware
$20K

Top Sellers

1
ACM
1
Altium Capital Management
New York
$0
2
PAM
2
PVG Asset Management
Colorado
$98.6K
3
Envestnet Asset Management
3
Envestnet Asset Management
Illinois
$109K
4
TSS
4
Two Sigma Securities
New York
$0
5
Osaic Holdings
5
Osaic Holdings
Arizona
$31.7K
Name Holding Trade Value Shares
Change 		Shares
Change %
ACM
26
Altium Capital Management
New York
– -$2.02M -56,991 Closed
TSS
27
Two Sigma Securities
New York
– -$21.4K -604 Closed
BAM
28
Belpointe Asset Management
Nevada
– -$14.2K -400 Closed
1
2